KFDA Approves Revolutionary Stem Cell Therapy

BMI View: South Korea's approval of a stem cell treatment highlights the country's gradual acceptance of the therapeutic approach. However, because such treatments are costly and are associated with low efficacy rates, BMI believes they will not be used widely until scientists attain a better understanding of their properties.

To read the full article, please choose one of the following options: